Timiperone
Systematic (IUPAC) name | |
---|---|
1-(4-fluorophenyl)-4-[4-(2-sulfanylidene-3H-benzimidazol-1-yl)piperidin-1-yl]butan-1-one | |
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Legal status |
|
Routes of administration | Oral |
Identifiers | |
CAS Number | 57648-21-2 |
ATC code | None |
PubChem | CID 3033151 |
ChemSpider | 2297930 |
UNII | 626DQ7N19L |
KEGG | D02035 |
Chemical data | |
Formula | C22H24FN3OS |
Molar mass | 397.50 g/mol |
| |
| |
(what is this?) (verify) |
Timiperone is an antipsychotic of the butyrophenone class.[1][2]
References
- ↑ Pharmacological studies on timiperone, a new neuroleptic drug Part II: General pharmacological properties., Arzneimittelforschung. 1981;31(4):707-15, PMID 6113834 PubMed - indexed for MEDLINE
- ↑ Effect of Timiperone, a New Antipsychotic Drug, on the Sleep-Wakefulness Cycle in Cats, The Japanese Journal of Pharmacology, Vol.39 , No.3(1985)pp.391-394
This article is issued from Wikipedia - version of the Saturday, December 12, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.